![Roy F. J. Davis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roy F. J. Davis
Chief Tech/Sci/R&D Officer at Immunexpress, Inc.
Profile
Roy F.
J.
Davis is currently the Chief Medical Officer at Immunexpress, Inc. He obtained a doctorate degree from the Medical College of Virginia.
Roy F. J. Davis active positions
Companies | Position | Start |
---|---|---|
Immunexpress, Inc.
![]() Immunexpress, Inc. Miscellaneous Commercial ServicesCommercial Services Immunexpress, Inc. engages in development of revolutionary molecular diagnostics. The firm's SeptiCyte technology quantifies specific and multiple molecular markers from the patient?s own immune system for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. The company was founded by Richard Bruce Brandon, Roslyn Brandon and Mervyn Rees Thomas in and is headquartered in | Chief Tech/Sci/R&D Officer | 2015-10-21 |
Training of Roy F. J. Davis
Medical College of Virginia | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Immunexpress, Inc.
![]() Immunexpress, Inc. Miscellaneous Commercial ServicesCommercial Services Immunexpress, Inc. engages in development of revolutionary molecular diagnostics. The firm's SeptiCyte technology quantifies specific and multiple molecular markers from the patient?s own immune system for earlier detection and severity assessment of sepsis, as well as the better timing of drugs and other therapies. The company was founded by Richard Bruce Brandon, Roslyn Brandon and Mervyn Rees Thomas in and is headquartered in | Commercial Services |
- Stock Market
- Insiders
- Roy F. J. Davis